dr. P.C. (Peter) van den Akker

Clinical geneticist

dr. P.C. (Peter) van den Akker
Telephone:
+31 50 361 7100 (Secretary Department of Genetics, UMCG)
E-mail:
p.c.van.den.akker umcg.nl

Research

Publications
  1. Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants

    Overbeek, K. A., Rodríguez-Girondo, M. D., Wagner, A., van der Stoep, N., van den Akker, P. C., Oosterwijk, J. C., van Os, T. A., van der Kolk, L. E., Vasen, H. F. A., Hes, F. J., Cahen, D. L., Bruno, M. J. & Potjer, T. P., 1-Jun-2020, In : JOURNAL OF MEDICAL GENETICS. 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Mechanisms of Natural Gene Therapy in Dystrophic Epidermolysis Bullosa

    Kiritsi, D., Garcia, M., Brander, R., Has, C., Meijer, R., Jose Escamez, M., Kohlhase, J., van den Akker, P. C., Scheffer, H., Jonkman, M. F., del Rio, M., Bruckner-Tuderman, L. & Pasmooij, A. M. G., Aug-2014, In : Journal of Investigative Dermatology. 134, 8, p. 2097-2104 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa

    Bremer, J., van der Heijden, E. H., Eichhorn, D. S., Meijer, R., Lemmink, H. H., Scheffer, H., Sinke, R. J., Jonkman, M. F., Pasmooij, A. M. G. & Van den Akker, P. C., 18-Dec-2019, In : Molecular therapy - Nucleic acids. 18, p. 465-475 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Natural exon skipping reveals that antisense oligonucleotide-mediated exon skipping should be directed at the recessive type of dystrophic epidermolysis bullosa

    Bremer, J., van der Heijden, E. H., Eichhorn, D. S., Meijer, R., Lemmink, H. H., Scheffer, H., Sinke, R. S., Jonkman, M. F., Pasmooij, A. M. G. & Van den Akker, P. C., Oct-2019, In : European Journal of Human Genetics. 27, p. 1280-1281 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  5. Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.

    Potjer, T. P., Bollen, S., Grimbergen, A. J. E. M., van Doorn, R., Gruis, N. A., Asperen, C. J., Hes, F. J., van der Stoep, N. & Dutch Working Group for Clinical Oncogenetics, 15-May-2019, In : International Journal of Cancer. 144, 10, 13 p., 31984.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (44) »

Press / Media
  1. Huid Shivan net zo kwetsbaar als de vleugels van een vlinder

    Peter Akker, van den

    02/11/2019

    1 Media contribution

    Press/Media: Public Engagement ActivitiesPopular

  2. DEBRA Funds 4th year towards Novel Gene Technology for Epidermolysis Bullosa

    Peter Akker, van den

    01/06/201924/09/2019

    2 items of Media coverage

    Press/Media: OtherProfessional

View all (2) »

Activities
  1. Dutch Task Force for Genodermatology (External organisation)

    Peter Akker, van den (Member)
    2019

    Activity: MembershipMembership of networkProfessional

  2. Dutch Society for Experimental Dermatology (External organisation)

    Peter Akker, van den (Member)
    2019

    Activity: MembershipMembership of networkProfessional

  3. European Society for Dermatological Research (ESDR) (External organisation)

    Peter Akker, van den (Member)
    2019

    Activity: MembershipMembership of networkProfessional

View all (10) »

ID: 467566